This topic contains a solution. Click here to go to the answer

Author Question: The nocebo effect occurs when A) participants in a placebo study experience a negative effect. ... (Read 306 times)

Zoey63294

  • Hero Member
  • *****
  • Posts: 539
The nocebo effect occurs when
 
  A) participants in a placebo study experience a negative effect.
  B) participants in a placebo study experience a positive effect.
  C) experimenters use a double-blind study.
  D) experimenters use the case-control method.

Question 2

When neither the participants nor the experimenters know which group has received the treatment and which has received a placebo, the design is called
 
  A) confounding.
  B) double-blind.
  C) correlational.
  D) naturalistic.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dominiqueenicolee

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

A

Answer to Question 2

B




Zoey63294

  • Member
  • Posts: 539
Reply 2 on: Jun 21, 2018
Wow, this really help


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library